MEDBX
Price
$12.04
Change
-$0.02 (-0.17%)
Updated
Jun 6 closing price
Net Assets
7.12B
REBAX
Price
$9.55
Change
-$0.01 (-0.10%)
Updated
Jun 6 closing price
Net Assets
280.77M
Interact to see
Advertisement

MEDBX vs REBAX

Header iconMEDBX vs REBAX Comparison
Open Charts MEDBX vs REBAXBanner chart's image
MFS Emerging Markets Debt B
Price$12.04
Change-$0.02 (-0.17%)
VolumeN/A
Net Assets7.12B
Columbia Emerging Markets Bond A
Price$9.55
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets280.77M
MEDBX vs REBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MEDBX vs. REBAX commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDBX is a Hold and REBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDBX has more cash in the bank: 7.12B vs. REBAX (281M). MEDBX pays higher dividends than REBAX: MEDBX (5.69) vs REBAX (5.12). MEDBX was incepted earlier than REBAX: MEDBX (23 years) vs REBAX (19 years). MEDBX (1.82) is less costly to investors than REBAX (1.13). MEDBX is a more actively managed with annual turnover of: 58.00 vs. REBAX (41.00). MEDBX has a lower initial minimum investment than REBAX: MEDBX (1000) vs REBAX (2000). REBAX annual gain was more profitable for investors over the last year : 7.24 vs. MEDBX (6.32). REBAX return over 5 years is better than : 9.09 vs. MEDBX (6.21).
MEDBXREBAXMEDBX / REBAX
Total Expense Ratio1.811.13160%
Annual Report Gross Expense Ratio1.821.13161%
Fund Existence23 years19 years-
Gain YTD2.5353.25778%
Front LoadN/A5%-
Min. Initial Investment1000200050%
Min. Initial Investment IRAN/AN/A-
Net Assets7.12B281M2,533%
Annual Yield % from dividends5.695.12111%
Returns for 1 year6.327.2487%
Returns for 3 years16.5217.9492%
Returns for 5 years6.219.0968%
Returns for 10 years25.8532.7879%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGINX15.510.21
+1.37%
Macquarie Growth and Income A
TRGVX18.22N/A
N/A
T. Rowe Price Glbl Val Eq
HRCIX61.09N/A
N/A
Carillon ClariVest Capital Apprec I
INGFX35.26N/A
N/A
Invesco Oppenheimer International Gr R5
FSZIX9.78N/A
N/A
Fidelity Advisor Sustainable EM Eq I